Literature DB >> 15868936

Ellagic acid induced p53/p21 expression, G1 arrest and apoptosis in human bladder cancer T24 cells.

Te-Mao Li1, Guang-Wei Chen, Chin-Cheng Su, Jaung-Gung Lin, Chin-Chung Yeh, Kwork-Chu Cheng, Jing-Gung Chung.   

Abstract

It is well known that dietary phenolic compounds can elicit vital cellular responses such as cytotoxicity, cell cycle arrest and apoptosis by activating a cascade of molecular events. Ellagic acid is one of these phenolic compounds, but the exact mechanism of its action is still unclear. The objective of this study was to investigate ellagic acid-induced cell cycle arrest and apoptosis in T24 human bladder cancer cells in vitro. Assays were performed to determine cell viability, cell cycle arrest, apoptosis, caspases-3 activity and gene expression, measured by flow cytometric assay, polymerase chain reaction (PCR) and determination of caspase-3 activity. Ellagic acid significantly reduced the viable cells, induced G0/G1-phase arrest of the cell cycle and apoptosis. Ellagic acid also increased p53 and p21 and decreased CDK2 gene expression, that may lead to the G0/G1 arrest of T24 cells. Ellagic acid also promoted caspase-3 activity after exposure for 1, 3, 6, 12 and 24 h, which led to induction of apoptosis. Furthermore, the ellagic acid-induced apoptosis on T24 cells was blocked by the broad-spectrum caspase inhibitor (z-VAD-fmk).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15868936

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  32 in total

1.  Toxicogenomic activity of gemcitabine in two TP53-mutated bladder cancer cell lines: special focus on cell cycle-related genes.

Authors:  Glenda Nicioli da Silva; Elaine Aparecida de Camargo; Daisy Maria Favero Salvadori
Journal:  Mol Biol Rep       Date:  2012-10-09       Impact factor: 2.316

2.  BnRCH gene inhibits cell growth of Hela cells through increasing the G2 phase of cell cycle.

Authors:  Qian Wan; Zhibin Liu; Wenzhen Peng; Jianmei Wang; Xufeng Li; Yi Yang
Journal:  Hum Cell       Date:  2011-10-30       Impact factor: 4.174

3.  Mechanistic Nanotherapeutic Approach Based on siRNA-Mediated DJ-1 Protein Suppression for Platinum-Resistant Ovarian Cancer.

Authors:  Canan Schumann; Stephanie Chan; Oleh Khalimonchuk; Shannon Khal; Vitaliya Moskal; Vidhi Shah; Adam W G Alani; Olena Taratula; Oleh Taratula
Journal:  Mol Pharm       Date:  2016-05-26       Impact factor: 4.939

4.  Ellagic acid inhibits proliferation and induced apoptosis via the Akt signaling pathway in HCT-15 colon adenocarcinoma cells.

Authors:  Syed Umesalma; Ponnuraj Nagendraprabhu; Ganapasam Sudhandiran
Journal:  Mol Cell Biochem       Date:  2014-10-30       Impact factor: 3.396

5.  Ellagic acid, a natural polyphenolic compound, induces apoptosis and potentiates retinoic acid-induced differentiation of human leukemia HL-60 cells.

Authors:  Yuki Hagiwara; Takashi Kasukabe; Yasuhiko Kaneko; Nozomi Niitsu; Junko Okabe-Kado
Journal:  Int J Hematol       Date:  2010-06-18       Impact factor: 2.490

6.  Sub-millimolar concentration of the novel phenol-based compound, 2-hydroxy benzoate zinc, induces apoptosis in human HT-1080 fibrosarcoma cells.

Authors:  J G Mahdi; C J Pepper; M A Alkarrawi; A J Mahdi; I D Bowen
Journal:  Cell Prolif       Date:  2009-11-17       Impact factor: 6.831

7.  Ellagic acid checks lymphoma promotion via regulation of PKC signaling pathway.

Authors:  Sudha Mishra; Manjula Vinayak
Journal:  Mol Biol Rep       Date:  2012-10-31       Impact factor: 2.316

8.  Ellagic acid and human cancers: a systems pharmacology and docking study to identify principal hub genes and main mechanisms of action.

Authors:  Hamid Cheshomi; Ahmad Reza Bahrami; Maryam M Matin
Journal:  Mol Divers       Date:  2020-05-14       Impact factor: 2.943

9.  Synthesis and Antitumor Activity of Ellagic Acid Peracetate.

Authors:  Yulin Ren; Min Wei; Patrick C Still; Shunzong Yuan; Youcai Deng; Xiaozhuo Chen; Klaus Himmeldirk; A Douglas Kinghorn; Jianhua Yu
Journal:  ACS Med Chem Lett       Date:  2012-06-17       Impact factor: 4.345

10.  Ellagic Acid Attenuates BLM-Induced Pulmonary Fibrosis via Inhibiting Wnt Signaling Pathway.

Authors:  Xiaohe Li; Kai Huang; Xiaowei Liu; Hao Ruan; Ling Ma; Jingjing Liang; Yunyao Cui; Yanhua Wang; Shuyang Wu; Hailong Li; Yuli Wei; Zeping Li; Jingjing Gao; Bo Yang; Xiaoping Li; Guang Yang; Honggang Zhou; Cheng Yang
Journal:  Front Pharmacol       Date:  2021-04-12       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.